PMC:3342329 / 26255-26766 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T13045 0-3 PRP$ denotes Our
T13046 4-8 NNS denotes data
T13047 9-13 RB denotes thus
T13048 14-18 VBP denotes show
T13049 19-30 JJ denotes significant
T13050 31-39 JJ denotes clinical
T13051 40-52 NNS denotes implications
T13052 53-55 IN denotes of
T13053 56-60 NNP denotes CCR5
T13054 60-61 , denotes ,
T13055 62-69 IN denotes because
T13056 70-74 NNP denotes CCR5
T13057 75-77 VBZ denotes is
T13058 78-79 DT denotes a
T13059 80-81 NNP denotes G
T13060 82-89 NN denotes protein
T13061 90-97 VBN denotes coupled
T13062 98-106 NN denotes receptor
T13063 107-110 CC denotes and
T13064 111-113 PRP denotes it
T13065 114-116 VBZ denotes is
T13066 117-125 JJ denotes amenable
T13067 126-128 TO denotes to
T13068 129-132 VB denotes use
T13069 133-135 IN denotes as
T13070 136-137 DT denotes a
T13071 138-143 JJ denotes small
T13072 144-152 NN denotes molecule
T13073 153-156 IN denotes for
T13074 157-160 DT denotes the
T13075 161-171 NN denotes inhibition
T13076 172-174 IN denotes of
T13077 175-179 NNP denotes CCR5
T13078 179-180 . denotes .
T13079 181-188 JJ denotes Several
T13080 189-193 JJ denotes such
T13081 194-203 NNS denotes compounds
T13082 204-208 VBP denotes have
T13083 209-216 RB denotes already
T13084 217-221 VBN denotes been
T13085 222-227 VBN denotes shown
T13086 228-230 TO denotes to
T13087 231-233 VB denotes be
T13088 234-238 JJ denotes safe
T13089 239-241 IN denotes in
T13090 242-250 JJ denotes clinical
T13091 251-257 NNS denotes trials
T13092 258-261 IN denotes for
T13093 262-265 NN denotes use
T13094 266-268 IN denotes in
T13095 269-276 JJ denotes certain
T13096 277-285 NNS denotes diseases
T13097 286-290 JJ denotes such
T13098 291-293 IN denotes as
T13099 294-297 NNP denotes HIV
T13100 298-299 NNP denotes [
T13101 299-301 CD denotes 53
T13102 301-302 NNP denotes ]
T13103 302-303 . denotes .
T13104 304-308 RB denotes Thus
T13105 308-309 , denotes ,
T13106 310-312 PRP denotes we
T13107 313-320 VBP denotes believe
T13108 321-325 NNP denotes CCR5
T13109 326-328 VBZ denotes is
T13110 329-330 DT denotes a
T13111 331-337 NN denotes cancer
T13112 338-344 NN denotes target
T13113 345-349 WDT denotes that
T13114 350-358 VBZ denotes warrants
T13115 359-368 VBN denotes continued
T13116 369-382 NN denotes investigation
T13117 382-383 . denotes .
T13118 384-386 IN denotes In
T13119 387-394 NN denotes summary
T13120 394-395 , denotes ,
T13121 396-400 DT denotes this
T13122 401-406 NN denotes study
T13123 407-413 VBD denotes showed
T13124 414-418 IN denotes that
T13125 419-427 NN denotes melanoma
T13126 428-433 NNS denotes cells
T13127 434-440 NN denotes growth
T13128 441-444 VBD denotes was
T13129 445-454 VBN denotes inhibited
T13130 455-458 IN denotes via
T13131 459-469 NN denotes modulation
T13132 470-472 IN denotes of
T13133 473-478 NNP denotes NF-κB
T13134 478-479 NNP denotes /
T13135 479-485 NNP denotes IL-1Ra
T13136 486-494 NNS denotes pathways
T13137 495-497 IN denotes in
T13138 498-502 CD denotes CCR5
T13139 502-503 CD denotes
T13140 503-504 NN denotes /
T13141 504-505 NN denotes
T13142 506-510 NNS denotes mice
T13143 510-511 . denotes .
R8897 T13085 T13085 ROOT shown,shown
R8898 T13086 T13087 aux to,be
R8900 T13087 T13085 xcomp be,shown
R8901 T13088 T13087 acomp safe,be
R8902 T13089 T13088 prep in,safe
R8904 T13090 T13091 amod clinical,trials
R8905 T13091 T13089 pobj trials,in
R8907 T13092 T13087 prep for,be
R8908 T13093 T13092 pobj use,for
R8909 T13094 T13093 prep in,use
R8911 T13095 T13096 amod certain,diseases
R8912 T13096 T13094 pobj diseases,in
R8913 T13097 T13098 amod such,as
R8915 T13098 T13096 prep as,diseases
R8916 T13099 T13100 compound HIV,[
R8918 T13100 T13098 pobj [,as
R8919 T13101 T13102 nummod 53,]
R8920 T13102 T13100 conj ],[
R8922 T13103 T13085 punct .,shown
R8923 T13104 T13107 advmod Thus,believe
R8924 T13105 T13107 punct ",",believe
R8926 T13106 T13107 nsubj we,believe
R8927 T13107 T13107 ROOT believe,believe
R8928 T13108 T13109 nsubj CCR5,is
R8930 T13109 T13107 ccomp is,believe
R8931 T13110 T13112 det a,target
R8932 T13111 T13112 compound cancer,target
R8933 T13112 T13109 attr target,is
R8935 T13113 T13116 dobj that,investigation
R8936 T13114 T13115 nsubj warrants,continued
R8939 T13115 T13116 amod continued,investigation
R8943 T13116 T13112 appos investigation,target
R8944 T13117 T13107 punct .,believe
R8945 T13118 T13123 prep In,showed
R8946 T13119 T13118 pobj summary,In
R8947 T13120 T13123 punct ",",showed
R8949 T13121 T13122 det this,study
R8950 T13122 T13123 nsubj study,showed
R8951 T13123 T13123 ROOT showed,showed
R8952 T13124 T13129 mark that,inhibited
R8954 T13125 T13126 compound melanoma,cells
R8955 T13126 T13127 compound cells,growth
R8957 T13127 T13129 nsubjpass growth,inhibited
R8958 T13128 T13129 auxpass was,inhibited
R8960 T13129 T13123 ccomp inhibited,showed
R8961 T13130 T13129 prep via,inhibited
R8962 T13131 T13130 pobj modulation,via
R8964 T13132 T13131 prep of,modulation
R8965 T13133 T13135 compound NF-κB,IL-1Ra
R8966 T13134 T13135 compound /,IL-1Ra
R8968 T13135 T13136 compound IL-1Ra,pathways
R8969 T13136 T13132 pobj pathways,of
R8970 T13137 T13129 prep in,inhibited
R8972 T13138 T13142 nummod CCR5,mice
R8973 T13139 T13142 nummod −,mice
R8974 T13140 T13142 nmod /,mice
R8976 T13141 T13142 compound −,mice
R8977 T13142 T13137 pobj mice,in
R8978 T13143 T13123 punct .,showed
R8994 T13045 T13046 poss Our,data
R8995 T13046 T13048 nsubj data,show
R8996 T13047 T13048 advmod thus,show
R8997 T13048 T13048 ROOT show,show
R8998 T13049 T13051 amod significant,implications
R8999 T13050 T13051 amod clinical,implications
R9000 T13051 T13048 dobj implications,show
R9001 T13052 T13051 prep of,implications
R9002 T13053 T13052 pobj CCR5,of
R9003 T13054 T13048 punct ",",show
R9004 T13055 T13057 mark because,is
R9005 T13056 T13057 nsubj CCR5,is
R9006 T13057 T13048 advcl is,show
R9007 T13058 T13060 det a,protein
R9008 T13059 T13060 compound G,protein
R9009 T13060 T13057 attr protein,is
R9010 T13061 T13060 acl coupled,protein
R9011 T13062 T13061 dobj receptor,coupled
R9012 T13063 T13057 cc and,is
R9013 T13064 T13065 nsubj it,is
R9014 T13065 T13057 conj is,is
R9015 T13066 T13065 acomp amenable,is
R9016 T13067 T13068 aux to,use
R9017 T13068 T13066 xcomp use,amenable
R9018 T13069 T13068 prep as,use
R9019 T13070 T13072 det a,molecule
R9020 T13071 T13072 amod small,molecule
R9021 T13072 T13069 pobj molecule,as
R9022 T13073 T13072 prep for,molecule
R9023 T13074 T13075 det the,inhibition
R9024 T13075 T13073 pobj inhibition,for
R9025 T13076 T13075 prep of,inhibition
R9026 T13077 T13076 pobj CCR5,of
R9027 T13078 T13048 punct .,show
R9028 T13079 T13081 amod Several,compounds
R9029 T13080 T13081 amod such,compounds
R9030 T13081 T13085 nsubj compounds,shown
R9031 T13082 T13085 aux have,shown
R9032 T13083 T13085 advmod already,shown
R9033 T13084 T13085 auxpass been,shown